Access to anti-retroviral drugs, male in Maldives

Maldives: Access to anti-retroviral drugs, male was 60.0% in 2024. ◆ Volatile

Latest (2024)
60.0%
Change on year
up 15.4%
World rank
102nd
of 141 countries
All-time high
98.0%
in 2007
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Maldives, 2000–2024

0204060801002000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 0 %2006: 0 %2007: 98 %2008: 98 %2009: 98 %2010: 15 %2011: 20 %2012: 30 %2013: 33 %2014: 35 %2015: 41 %2016: 38 %2017: 42 %2018: 38 %2019: 50 %2020: 54 %2021: 53 %2022: 52 %2023: 52 %2024: 60 %

Source: UNAIDS estimates. Measured in %.

Analysis

Maldives recorded 60.0% for access to anti-retroviral drugs, male in 2024.

Compared with earlier readings it is up 15.4% on the previous year and up 71.4% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Maldives peaked at 98.0% in 2007 and was at its lowest, 0.0%, in 2000.

That places Maldives 102nd out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Maldives, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Maldives, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 0.0%
2007 98.0%
2008 98.0% +0.0%
2009 98.0% +0.0%
2010 15.0% -84.7%
2011 20.0% +33.3%
2012 30.0% +50.0%
2013 33.0% +10.0%
2014 35.0% +6.1%
2015 41.0% +17.1%
2016 38.0% -7.3%
2017 42.0% +10.5%
2018 38.0% -9.5%
2019 50.0% +31.6%
2020 54.0% +8.0%
2021 53.0% -1.9%
2022 52.0% -1.9%
2023 52.0% +0.0%
2024 60.0% +15.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 29.4% 0.0% 98.0% 10
2010s 34.2% 15.0% 50.0% 10
2020s 54.2% 52.0% 60.0% 5

Countries ranked near Maldives

  1. 102 Albania 60.0% compare
  2. 102 North Macedonia 60.0% compare
  3. 105 Bolivia, Plurinational State of 59.0% compare
  4. 105 Malaysia 59.0% compare
  5. 105 Syrian Arab Republic 59.0% compare
  6. 105 Venezuela, Bolivarian Republic of 59.0% compare

See the full ranking of 160 places →

More gender data for Maldives

All data for Maldives →

Frequently asked questions

What is access to anti-retroviral drugs, male in Maldives?
Access to anti-retroviral drugs, male in Maldives was 60.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Maldives?
The highest recorded value was 98.0% in 2007.
What is the lowest access to anti-retroviral drugs, male recorded in Maldives?
The lowest recorded value was 0.0% in 2000.
How does Maldives rank for access to anti-retroviral drugs, male?
Maldives ranks 102nd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Maldives?
Over the last ten years it is up 71.4%. The long-run trend across the full record is volatile.
Where does this Maldives data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Maldives. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/maldives/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/maldives/">Access to anti-retroviral drugs, male in Maldives</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.